Clinical Research Manager - Motor Neuron (10 h/week)
Ref.: 23-253_SS_MP
About the research group
Neurologic Diseases and Neurogenetics
MOTOR NEURON UNIT: The unit, led by Dr. Povedano, is a reference center for motor neuron pathology in the region and nationally (CSUR), and is in the European reference network of rare neuromuscular disorders (ERN_NMD). The unit is an expert center in intrathecal treatment of adult SMA, too. In the past, Dr Povedano training in the disease was extended with two stays abroad (Columbia/NY, Dr. Mitsumoto; and California Pacific Medical center/SFCO, Dr. Miller). The unit's fellows also have been in NY, London, Utrech and Nijmegen; being each stay focused on a specific topic: clinical, genomic and ALS ultrasound studies, respectively. Nowadays, Dr. Povedano is on the board of the European Network TRICALS (https://www.tricals.org/es/), the European platform for the coordination of basic and clinical research in patients with ALS, as well as for conducting clinical trials; and being validated in different techniques. Our group is also adhered to European Network to Cure ALS (ENCALS). In turn, it is part of Project MINE, a European project for genome sequencing in patients with ALS and controls, as well as the subproject focused on the clinical and genetic study of African populations, which is carried out within the framework of the MINE project. In this sense, she collaborates with the University of Addis Ababa in the training of neurologists in EMG, carrying out training courses and studies in the field of motor neuron diseases. Dr. Povedano is, together with Dr. Orla Hardiman (Consultant Neurologist, and Head of Academic Unit Neurology of the Trinity Collage of Dublin); part of the LATAM group epidemiological studies in South America and in the “Precision ALS: Patient Data platform”, enabling a definitive precision medicine approach to new drug development in neurodegeneration. The Unit has a collection of samples from ALS patients registered in the “Instituto de Salud Carlos III (ISCIII) [CSF, skin, stool, blood, DNA] which has allowed collaboration with basic groups that are part of CIBERNED and also with international groups. The IP is contributing to different projects and published works, establishing a consolidated network available in the future for new projects and collaborations. Among the different research groups, the IP has collaborated with Dr. Ammar al Chalabi group of the “Maurice Wohl Clinical Neuroscience Institute” of the King’s College London (SOPHIA); Dr. Leonard Van den Berg group of the University Medical Center of Utrech (project MINE); Dr. Marc Saez and Dr. Antonia Barceló of the research group on statistics, econometrics and health (GRECS) of the University of Girona and CIBER of Epidemiology and Public Health (CIBERESP); Dr. Manuel Portero Otín group of the IRB-Lleida-Universitat de Lleida; Dr. Rubén López Vales group of the “Dept. Biologia Cel·lular, Fisiologia i Immunologia” of the “Institut de Neurociències”- Universitat Autonoma de Barcelona (UAB) and CIBERNED; and Dr. Alberto García Redondo group, of the “Laboratorio de Investigación en ELA” of the Investigación Sanitaria Hospital 12 de Octubre.
About the role
CLINICAL RESEARCH MANAGER in Clinical Trials.
Job requirements
Professional experience
-
Experience in Public Spanish Health System
-
Previous experience in clinical trials
-
Experience working with motor neuron disease patients (especially ALS patients)
Education and training
-
University Degree in Health
-
Training in clinical trials
-
Good Clinical Practices certificate
-
Advanced knowledge of data warehouse management
-
Knowledge of Python, R and/or SQL programming languages
Technical & soft skills
Languages
We will value, but not required
- Good organization and project managing
- Motivation, initiative and learning ability
- Teamwork
What do we offer
-
-
Estimated start date: 02/11/2023
-
Contract duration: Permanent linekd to projects (Part-time contract)
-
Estimated annual gross salary: It is commensurate with qualifications and consistent with our pay ranges (15 h/week).
-
You will be part of a multicultural team. We have a fun loving and friendly international work environment.
-
Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
-
Possibility to work some days in remote -Teleworking
-
26 working days of holiday per year
-
System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
-
-
Benefits of constant training are offered
-
We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
Deadline: Please submit your application by 26/10/2023
Data protection notice
In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
Observations
The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).
The project leading to this labour contract has received funding from STICHTING TRICALS FOUNDATION under various project codes.
